Researcher
Ivan Van Riet
- Research Expertise:
- Bone marrow and peripheral blood stem cells: biology and therapeutical use
- Stem cell processing and banking
- Tumo-host interactions in blood cancer (multiple myeloma)
- Keywords:Medicine
- Disciplines:Cancer biology, Stem cell biology, Clinical hematology, Cancer therapy, Hematology
- Users of research expertise:
- Bone marrow and peripheral blood stem cells: biology and therapeutical use
- Stem cell processing and banking
- Tumo-host interactions in blood cancer (multiple myeloma)
Affiliations
- Translational Oncology Research Center (Research group)
Member
From1 Jan 2023 → Today - Hematology (Department)
Member
From1 Jun 2010 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2024 → Today - Basic (bio-) Medical Sciences (Department)
Member
From8 Apr 2019 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 20 Oct 2022 - Immunology and Microbiology (Department)
Member
From1 Oct 2005 → 31 Dec 2013 - Immunology and Microbiology (Department)
Member
From1 Oct 2002 → 30 Sep 2005 - FORMER_Hematology (Research group)
Member
From1 Oct 1999 → 1 Jan 2023 - Immunology and Microbiology (Department)
Member
From1 Sep 1992 → 31 Aug 1993
Projects
1 - 3 of 3
- TBM Project: Ultra-sensitive minimal residual disease assessment by blood-based clonotypic mass spectrometry approach in plasma cell dyscrasias (MASSIAS)From1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Tumor characterization and disease follow-up in multiple myeloma by (epi) genetic profiling using liquid biopsiesFrom1 Nov 2021 → TodayFunding: FWO junior postdoctoral fellowship
- Tumor-microenvoronment interactions in multiple myeloma: regulation by epigenetic modifications and hypoxia.From1 Jan 2010 → 31 Dec 2013Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 52
- Een innovatieve, niet-invasieve strategie voor mutatieanalyse bij multipel myeloom: liquid biopsies op de weg naar gepersonaliseerde geneeskunde(2024)
Authors: Robbe Heestermans, Rik Schots, Ann De Becker, Ivan Van Riet
Pages: 22-24 - The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis(2024)
Authors: Evelyn Stephany Calderon Espinosa, Kirsten De Ridder, Thomas Benoot, Yanina Jansen, Domien Vanhonacker, Robbe Heestermans, Ann De Becker, Ivan Van Riet, Lore Decoster, Cleo Goyvaerts
- A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells in solid tumors(2024)
Authors: Manon Vounckx, Jens Tijtgat, Latoya Stevens, Iris Dirven, Bart Ilsen, Frederik Vandenbroucke, Steven P M J Raeymaeckers, Karolien Vekens, Ramses G Forsyth, Xenia Geeraerts, et al.
- Preanalytical variables influencing the interpretation and reporting of biological tests on blood samples of living and deceased donors for human body materials(2024)
Authors: Elizaveta Padalko, Luc Colenbie, Alain Delforge, Nadine Ectors, Johan Guns, Romain Imbert, Hilde Jansens, Jean-Paul Pirnay, Marie-Pierre Rodenbach, Ivan Van Riet, et al.
Pages: 509-520 - Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities(2024)
Authors: Robbe Heestermans, Rik Schots, Ann De Becker, Ivan Van Riet
- Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma(2024)
Authors: Jens Tijtgat, Xenia Geeraerts, Anais Boisson, Latoya Stevens, Manon Vounckx, Iris Dirven, Julia Katharina Schwarze, Steven P M J Raeymaeckers, Ramses G Forsyth, Ivan Van Riet, et al.
- Influence of in vitro expansion conditions on biological properties of bone marrow-derived mesenchymal stromal cells(2023)
Authors: Ann De Becker, Ivan Van Riet
Number of pages: 170 - Genetic profiling of human bone marrow mesenchymal stromal cells after in vitro expansion in clinical grade human platelet lysate(2022)
Authors: Ann De Becker, Robbe Heestermans, Wouter De Brouwer, Kara Bockstaele, Ken Maes, Ivan Van Riet
- Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study(2022)
Authors: Robbe Heestermans, Wouter De Brouwer, Ken Maes, Isabelle Vande Broek, Freya Vaeyens, Catharina Olsen, Ben Caljon, Ann De Becker, M.H.C. Bakkus, Rik Schots, et al.
- Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients(2022)
Authors: Julia Katharina Schwarze, Jens Tijtgat, Gil Awada, Louise Cras, Angela Vasaturo, Christopher Bagnall, Ramses G Forsyth, Ines Dufait, Sandra Tuyaerts, Ivan Van Riet, et al.
Pages: 1-13